Invizyne Technologies (IZTC) Stock Price, News & Analysis

Company Overview

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Key Stats

• Today's Range: $17.00 to $19.65
• 50-Day Range: N/A
• 52-Week Range: $8.50 to $20.00
• Volume: 111,165 shs
• Average Volume: 40,626 shs
• Market Capitalization: $116.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IZTC Stock Analysis - Frequently Asked Questions

How have IZTC shares performed this year?

Invizyne Technologies' stock was trading at $10.36 on January 1st, 2024. Since then, IZTC shares have increased by 79.2% and is now trading at $18.57.
View the best growth stocks for 2024 here.

When did Invizyne Technologies IPO?

Invizyne Technologies (IZTC) raised $15 million in an IPO on Wednesday, November 13th 2024. The company issued 1,875,000 shares at $8.00 per share.

When does Invizyne Technologies' quiet period expire?

Invizyne Technologies' quiet period expires on Monday, December 23rd. Invizyne Technologies had issued 1,875,000 shares in its public offering on November 13th. The total size of the offering was $15,000,000 based on an initial share price of $8.00. During Invizyne Technologies' quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Invizyne Technologies?

Shares of IZTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IZTC
• CUSIP: N/A
• CIK: 2010788
• Web: www.invizyne.com
• Phone: 626-415-1488
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,252,000
• Free Float: N/A
• Market Cap: $116.10 million
• Optionable: N/A
• Beta: N/A